Minor completed stroke will be included in aspirin professional labeling, FDA clarifies.
This article was originally published in The Tan Sheet
Executive Summary
MINOR COMPLETED STROKE WILL BE INCLUDED IN ASPIRIN PROFESSIONAL LABELING, FDA OTC Drug Division Director Debra Bowen, MD, clarifies in an Oct. 16 letter to Charles Hennekens, MD/PhD, Harvard Medical School. In a June 12 letter to Hennekens, Bowen had reported that FDA did not intend to recommend aspirin professional labeling for completed stroke. Hennekens is chairman of the industry-funded Aspirin Strategy Group, "an ad hoc committee of independent scientists."